261 related articles for article (PubMed ID: 12432281)
21. [The relationship between the TSLC1 silencing and DNA methylation in human lung cancer cells].
Ming S; Gao J; Sun T
Zhongguo Fei Ai Za Zhi; 2010 May; 13(5):464-9. PubMed ID: 20677643
[TBL] [Abstract][Full Text] [Related]
22. Identification and characterization of differentially methylated CpG islands in pancreatic carcinoma.
Ueki T; Toyota M; Skinner H; Walter KM; Yeo CJ; Issa JP; Hruban RH; Goggins M
Cancer Res; 2001 Dec; 61(23):8540-6. PubMed ID: 11731440
[TBL] [Abstract][Full Text] [Related]
23. Analysis of 11q21-24 loss of heterozygosity candidate target genes in breast cancer: indications of TSLC1 promoter hypermethylation.
Allinen M; Peri L; Kujala S; Lahti-Domenici J; Outila K; Karppinen SM; Launonen V; Winqvist R
Genes Chromosomes Cancer; 2002 Aug; 34(4):384-9. PubMed ID: 12112527
[TBL] [Abstract][Full Text] [Related]
24. Involvement of TSLC1 in progression of esophageal squamous cell carcinoma.
Ito T; Shimada Y; Hashimoto Y; Kaganoi J; Kan T; Watanabe G; Murakami Y; Imamura M
Cancer Res; 2003 Oct; 63(19):6320-6. PubMed ID: 14559819
[TBL] [Abstract][Full Text] [Related]
25. CpG island methylation profile of pancreatic intraepithelial neoplasia.
Sato N; Fukushima N; Hruban RH; Goggins M
Mod Pathol; 2008 Mar; 21(3):238-44. PubMed ID: 18157091
[TBL] [Abstract][Full Text] [Related]
26. Silencing of the hypoxia-inducible cell death protein BNIP3 in pancreatic cancer.
Okami J; Simeone DM; Logsdon CD
Cancer Res; 2004 Aug; 64(15):5338-46. PubMed ID: 15289340
[TBL] [Abstract][Full Text] [Related]
27. RASSF1 tumor suppressor gene in pancreatic ductal adenocarcinoma: correlation of expression, chromosomal status and epigenetic changes.
Amato E; Barbi S; Fassan M; Luchini C; Vicentini C; Brunelli M; Malleo G; Scarpa A; Malpeli G
BMC Cancer; 2016 Jan; 16():11. PubMed ID: 26754001
[TBL] [Abstract][Full Text] [Related]
28. Multiple genes are hypermethylated in intraductal papillary mucinous neoplasms of the pancreas.
Hong SM; Kelly D; Griffith M; Omura N; Li A; Li CP; Hruban RH; Goggins M
Mod Pathol; 2008 Dec; 21(12):1499-507. PubMed ID: 18820670
[TBL] [Abstract][Full Text] [Related]
29. Inactivation of the 14-3-3 sigma gene is associated with 5' CpG island hypermethylation in human cancers.
Suzuki H; Itoh F; Toyota M; Kikuchi T; Kakiuchi H; Imai K
Cancer Res; 2000 Aug; 60(16):4353-7. PubMed ID: 10969776
[TBL] [Abstract][Full Text] [Related]
30. Expression of TSLC1, a candidate tumor suppressor gene mapped to chromosome 11q23, is downregulated in unfavorable neuroblastoma without promoter hypermethylation.
Ando K; Ohira M; Ozaki T; Nakagawa A; Akazawa K; Suenaga Y; Nakamura Y; Koda T; Kamijo T; Murakami Y; Nakagawara A
Int J Cancer; 2008 Nov; 123(9):2087-94. PubMed ID: 18726896
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathological significance and molecular regulation of maspin expression in ductal adenocarcinoma of the pancreas.
Ohike N; Maass N; Mundhenke C; Biallek M; Zhang M; Jonat W; Lüttges J; Morohoshi T; Klöppel G; Nagasaki K
Cancer Lett; 2003 Sep; 199(2):193-200. PubMed ID: 12969792
[TBL] [Abstract][Full Text] [Related]
32. Aberrant methylation of CpG islands in intraductal papillary mucinous neoplasms of the pancreas.
Sato N; Ueki T; Fukushima N; Iacobuzio-Donahue CA; Yeo CJ; Cameron JL; Hruban RH; Goggins M
Gastroenterology; 2002 Jul; 123(1):365-72. PubMed ID: 12105864
[TBL] [Abstract][Full Text] [Related]
33. Epigenetic down-regulation of CDKN1C/p57KIP2 in pancreatic ductal neoplasms identified by gene expression profiling.
Sato N; Matsubayashi H; Abe T; Fukushima N; Goggins M
Clin Cancer Res; 2005 Jul; 11(13):4681-8. PubMed ID: 16000561
[TBL] [Abstract][Full Text] [Related]
34. TSLC1 is a tumor-suppressor gene in human non-small-cell lung cancer.
Kuramochi M; Fukuhara H; Nobukuni T; Kanbe T; Maruyama T; Ghosh HP; Pletcher M; Isomura M; Onizuka M; Kitamura T; Sekiya T; Reeves RH; Murakami Y
Nat Genet; 2001 Apr; 27(4):427-30. PubMed ID: 11279526
[TBL] [Abstract][Full Text] [Related]
35. Genome-wide analysis of promoter methylation associated with gene expression profile in pancreatic adenocarcinoma.
Vincent A; Omura N; Hong SM; Jaffe A; Eshleman J; Goggins M
Clin Cancer Res; 2011 Jul; 17(13):4341-54. PubMed ID: 21610144
[TBL] [Abstract][Full Text] [Related]
36. Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma.
Byun DS; Lee MG; Chae KS; Ryu BG; Chi SG
Cancer Res; 2001 Oct; 61(19):7034-8. PubMed ID: 11585730
[TBL] [Abstract][Full Text] [Related]
37. Reduced expression of the Tslc1 gene and its aberrant DNA methylation in rat lung tumors.
Shimizu K; Itsuzaki Y; Onishi M; Fujii H; Honoki K; Tsujiuchi T
Biochem Biophys Res Commun; 2006 Aug; 347(1):358-62. PubMed ID: 16814249
[TBL] [Abstract][Full Text] [Related]
38. Early epigenetic downregulation of WNK2 kinase during pancreatic ductal adenocarcinoma development.
Dutruel C; Bergmann F; Rooman I; Zucknick M; Weichenhan D; Geiselhart L; Kaffenberger T; Rachakonda PS; Bauer A; Giese N; Hong C; Xie H; Costello JF; Hoheisel J; Kumar R; Rehli M; Schirmacher P; Werner J; Plass C; Popanda O; Schmezer P
Oncogene; 2014 Jun; 33(26):3401-10. PubMed ID: 23912455
[TBL] [Abstract][Full Text] [Related]
39. Alterations of BLU, a candidate tumor suppressor gene on chromosome 3p21.3, in human nasopharyngeal carcinoma.
Liu XQ; Chen HK; Zhang XS; Pan ZG; Li A; Feng QS; Long QX; Wang XZ; Zeng YX
Int J Cancer; 2003 Aug; 106(1):60-5. PubMed ID: 12794757
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic inactivation of TFPI-2 as a common mechanism associated with growth and invasion of pancreatic ductal adenocarcinoma.
Sato N; Parker AR; Fukushima N; Miyagi Y; Iacobuzio-Donahue CA; Eshleman JR; Goggins M
Oncogene; 2005 Jan; 24(5):850-8. PubMed ID: 15592528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
